Grant RDF

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...

• AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
• AALL1621- A Phase 2 Study of Inotuzumab Ozogamicin (NSC#772518, IND#133494) in Children and Young Adults with Relapsed or Refractory CD22+B-Acute Lymphoblastic Leukemia(B-ALL)
• AAML 1031 - A Phase III Randomized Trial for Patients with De Novo AML Using Bortezomib (NSC# 681239) and Sorafenib (BAY 43-9006, NSC# 724772) for Patients with High Allelic Ratio FLT2/ITD
• AAML 1031 - Bayer
• AAV-Based Plasmacytoid Dentritic Cell Cancer Vaccine
• AAV-Mediated Gene Therapy for Metabolic Bone Disease
• Abbott Fund Interventional Fellowship Grant 2017-2018
• Abbott Fund Interventional Fellowship Grant 2018-2019
• Abbott Interventional Fellowship 2012/2013
• Abbott Interventional Fellowship Grant 2013-2014
• Abbott Interventional Fellowship Grant 2014-2015
• Abbott Interventional Fellowship Grant 2015-2016
• Abbott Interventional Fellowship Grant 2016-2017
• Aberrant Circadian Regulation Of Autophagy In The Heart During Diabetes
• Aberrant NFkB Signaling in Alzheimer's Disease and its Effects on Neural Stem Cells.
• Abnormal Late Endosomal Trafficking in Frontotemporal Dementia due to Progranulin Mutations
• Abnormal STAT3 Signaling and Aberrant O-Glycosylation of IgA1 in IgA Nephropathy
• Abnormalities of Glutamate Transporter Localization in Schizophrenia
• Abnormalities of Glutamate Transporter Localization in Schizophrenia
• Academic Performance Interventions in the Prevention of Childhood Obesity; a Systematic Review and Meta-Analysis
• Academic-Practice Partnership for a Healthier Alabama
• Accelerating Inflammation Resolution to CounterACT Chemical Injury
• Accelerating Inflammation Resolution to Counteract Chemical Injury
• Accelerating Translational Bioenergetics at UAB
• Acceleration of Skin Repair by Adipose-Derived Mesenchymal Cells
• Access Improvement and Management for Epilepsy with Telehealth (AIM-ET)
• Access to Abortion Care in the Deep South
• Access to Healthcare Among Homeless Persons in Birmingham
• Accurate Profiles of IgA1 O-Glycans Heterogeneity in IgA Nephropathy
• ACE - Switching Anti-TNF-a Agents in Patients with RA with an Inadequate Response to TNF-a Inhibition - ACE

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...